Literature DB >> 1943489

Drug distribution studies with microdialysis. III: Extracellular concentration of caffeine in adipose tissue in man.

L Ståhle1, P Arner, U Ungerstedt.   

Abstract

Microdialysis was applied to estimate the extracellular concentration of caffeine in subcutaneous abdominal adipose tissue of five healthy volunteers after oral administration of approximately 5 mg/kg (300 or 400 mg) of caffeine. The peak extracellular levels were in the range of 20 - 80 microM. The time-course in blood and in extracellular fluid was similar but the plateau concentrations were not closely correlated. The estimated mean concentration of five individuals was similar in blood and extracellular fluid. The intraindividual variation between probes was found to be small compared to the interindividual variation (8% versus 43%). It is concluded that microdialysis yield useful data on drug distribution in man and that distribution to adipose tissue may not strictly follow the concentrations in blood. A comparison with available information of the in vitro properties of caffeine shows that the levels attained in the extracellular fluid were too small to significantly affect phosphodiesterase but sufficiently high to block adenosine receptors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1943489     DOI: 10.1016/0024-3205(91)90488-w

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  35 in total

1.  Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients.

Authors:  M Müller; M Brunner; U Hollenstein; C Joukhadar; R Schmid; E Minar; H Ehringer; H G Eichler
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

2.  Distribution and antimicrobial activity of ciprofloxacin in human soft tissues.

Authors:  M Brunner; U Hollenstein; S Delacher; D Jäger; R Schmid; E Lackner; A Georgopoulos; H G Eichler; M Müller
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

3.  Target site concentrations of ciprofloxacin after single intravenous and oral doses.

Authors:  Martin Brunner; Heino Stabeta; Jan-Georg Möller; Claudia Schrolnberger; Boban Erovic; Ursula Hollenstein; Markus Zeitlinger; Hans Georg Eichler; Markus Müller
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

4.  Pharmacokinetic estimations from microdialysis data.

Authors:  L Ståhle
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 5.  Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: distribution in tissue.

Authors:  Markus Müller; Amparo dela Peña; Hartmut Derendorf
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

Review 6.  Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the future.

Authors:  Christian Joukhadar; Markus Müller
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

7.  Pharmacokinetics of unbound linezolid in plasma and tissue interstitium of critically ill patients after multiple dosing using microdialysis.

Authors:  Cornelia Buerger; Nele Plock; Pejman Dehghanyar; Christian Joukhadar; Charlotte Kloft
Journal:  Antimicrob Agents Chemother       Date:  2006-07       Impact factor: 5.191

Review 8.  Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution.

Authors:  Martin Brunner; Oliver Langer
Journal:  AAPS J       Date:  2006-04-14       Impact factor: 4.009

9.  Assessment of topical bioequivalence using dermal microdialysis and tape stripping methods.

Authors:  Tuba Incecayir; Ilbeyi Agabeyoglu; Ulver Derici; Sukru Sindel
Journal:  Pharm Res       Date:  2011-04-16       Impact factor: 4.200

10.  Pilot investigation on long-term subcutaneous microdialysis: proof of principle in humans.

Authors:  Franziska Simmel; Claudia Kirbs; Zeynep Erdogan; Edith Lackner; Markus Zeitlinger; Charlotte Kloft
Journal:  AAPS J       Date:  2012-10-13       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.